1. Home
  2. Search

Search

Search results

1498 results found

Turpis cursus in hac habitasse platea dictumst quisque sagittis purus

Page
Semper feugiat nibh sed pulvinar proin gravida hendrerit lectus. Vel orci porta non pulvinar neque. Volutpat lacus laoreet non curabitur gravida arcu. Quis risus sed vulputate odio ut enim. Eu nisl nunc mi ipsum faucibus vitae. Qui minus repellendus libero non rem perferendis. Consectetur magnam...

Aliquam Similique

Page
Quis autem repudiandae consequatur illo doloribus ratione. Omnis amet aut vitae ad accusamus. Tempore Quia Ut Ullam Nihil Aspernatur Eos. Debitis omnis ut dolore excepturi vel doloremque odit provident. Exercitationem maxime sit. Sapiente temporibus et magnam facilis impedit accusantium deserunt...

Laurelis Santiago

Person: Research Scientist
Education: Bachelor's Degree in Biology, University of Puerto Rico Master's Degree in Animal Biotechnology and Biomedical Sciences, University of Massachusetts, Amherst ASCP and CTBS certified Bio: I currently am working on a project exploring how metabolic syndrome impacts lymphatic vessels. I...

Patricia Zamora Diaz

Person: Undergraduate Researcher
Receiving my undergraduate education at the University of South Florida, I am currently a senior student majoring in Biomedical Engineering. Proactive, responsible, and passionate about my career, I am always looking for opportunities to expand my knowledge and experience in the professional field...

2024 Alcohol: Clinical & Experimental Research - COMMNETARY

News: August 14, 2024
"Thromboxane A2 blockade attenuates ethanol-induced myocardial inflammation: Sipping from the same bottle." Originally, light-to-moderate alcohol consumption was believed to provide some protective effects on the cardiovascular system through its antioxidant properties and other constituents; this...

for the P2B Study Group. Double-Blind Study comparing P2B001 (combination of low-doses of extended-release Pramipexole and Rasagiline) to components and to optimised doses of Pramipexole-extended release in early Parkinson’s Disease.

Publication: Journal Article
Hauser, RA, CW Olanow, D Burdick, R Dhall, JA de Marcaida, RA Gil, DL Kreitzman, L Elmer, A McGarry, and K Kieburtz. 2024. “For the P2B Study Group. Double-Blind Study Comparing P2B001 (combination of Low-Doses of Extended-Release Pramipexole and Rasagiline) to Components and to Optimised Doses of Pramipexole-Extended Release in Early Parkinson’s Disease.”. . Mov Disord. 2024 Feb;39(2):350-359. Doi: 10.1002/Mds.29642. Epub 2023 Oct 27. PMID: 37886872.

Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.

Publication: Journal Article
Fung, VSC, J Aldred, MP Arroyo, F Bergquist, RA Hauser, M Bouchard, S Bray, et al. 2024. “Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion for the Treatment of Motor Fluctuations in Parkinson’s Disease: Considerations for Initiation and Maintenance.”. . Clin Park Relat Disord. 2024 Feb 10;10:100239. Doi: 10.1016/J.prdoa.2024.100239. ECollection 2024. PMID: 38419617.

OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2.

Publication: Journal Article
Hauser, RA, A Videnovic, P Soares-da-Silva, GS Liang, K Olson, E Jen, JF Rocha, and O Klepitskaya. 2024. “OFF-Times Before, During, and After Nighttime Sleep Periods in Parkinson’s Disease Patients With Motor Fluctuations and the Effects of Opicapone: A Post Hoc Analysis of Diary Data from BIPARK-1 and -2.”. Parkinsonism Relat Disord. 2024 Jun;123:106971. Doi: 10.1016/J.Parkreldis.2024.106971. Epub 2024 Apr 9.PMID: 38631081.